regulatory status raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-06-15 and is reviewed periodically as new material appears.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
| Property | Value | Notes |
|---|---|---|
| Solubility | Soluble in dimethyl sulfoxide and some organic solvents; practically insoluble in water | Solvent choice affects laboratory handling |
| Typical storage | -20 °C, desiccated, protected from light | Common condition for research samples |
| Analytical method | Liquid chromatography–tandem mass spectrometry (LC-MS/MS) | Used for identification and quantification in biological or product samples |
| Common synonyms | GW501516, GW-501516, GSK-516, Endurobol | Names found in research and anti-doping literature |
| Regulatory status | Unapproved therapeutic; prohibited in competitive sport | Status can vary by country and context |
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
Afonsoconus Tucker & Tenorio, 2013: synonym of Conus (Afonsoconus) Tucker & Tenorio, 2013 represented as Conus Linnaeus, 1758 Africonus Petuch, 1975: synonym of Conus (Lautoconus) Monterosato, 1923 represented as Conus Linnaeus, 1758 Arubaconus Petuch, 2013: synonym of Conus (Ductoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Asprella Schaufuss, 1869: synonym of Conus (Asprella) Schaufuss, 1869 represented as Conus Linnaeus, 1758 Atlanticonus Petuch & Sargent, 2012: synonym of Conus (Atlanticonus) Petuch & Sargent, 2012 represented as Conus Linnaeus, 1758 Attenuiconus Petuch, 2013: synonym of Conus (Attenuiconus) Petuch, 2013 represented as Conus Linnaeus, 1758 Austroconus Tucker & Tenorio, 2009 synonym of Conus (Austroconus) Tucker & Tenorio, 2009 represented as Conus Linnaeus, 1758 Bathyconus Tucker & Tenorio, 2009: synonym of Conasprella (Fusiconus) Thiele, 1929, represented as Conasprella Thiele, 1929 Bermudaconus Petuch, 2013: synonym of Conus (Bermudaconus) Petuch, 2013 represented as Conus Linnaeus, 1758 Boucheticonus Tucker & Tenorio, 2013: synonym of Conasprella (Boucheticonus) Tucker & Tenorio, 2013 represented as Conasprella Thiele, 1929 Brasiliconus Petuch, 2013: synonym of Conus (Brasiliconus) Petuch, 2013 represented as Conus Linnaeus, 1758 Calamiconus Tucker & Tenorio, 2009: synonym of Conus (Lividoconus) Wils, 1970 represented as Conus Linnaeus, 1758 Calibanus da Motta, 1991: synonym of Conus (Calibanus) da Motta, 1991 represented as Conus Linnaeus, 1758 Cariboconus Petuch, 2003: synonym of Conus (Dauciconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Californiconus Tucker & Tenorio, 2009 Chelyconus Mörch, 1852: synonym of Conus (Chelyconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Cleobula Iredale, 1930: synonym of Dendroconus Swainson, 1840 Coltroconus Petuch, 2013: synonym of Conasprella (Coltroconus) Petuch, 2013 represented as Conasprella Thiele, 1929 Conasprella Thiele, 1929: accepted name Conasprelloides Tucker & Tenorio, 2009: synonym of Conus (Dauciconus) Cotton, 1945 represented as Conus Linnaeus, 1758 † Conilithes Swainson, 1840 Continuconus Tucker & Tenorio, 2013 Conus Linnaeus, 1758: accepted name Cornutoconus Suzuki, 1972: synonym of Taranteconus Azuma, 1972 Coronaxis Swainson, 1840: synonym of Conus (Conus) Linnaeus, 1758 represented as Conus Linnaeus, 1758 Cucullus Röding, 1798: synonym of Conus (Conus) Linnaeus, 1758 represented as Conus Linnaeus, 1758 Cylinder Montfort, 1810: synonym of Conus (Cylinder) Montfort, 1810 represented as Conus Linnaeus, 1758 Cylindrella Swainson, 1840: synonym of Asprella Schaufuss, 1869synonym of Conus (Asprella) Schaufuss, 1869 represented as Conus Linnaeus, 1758 Cylindrus Batsch, 1789: synonym of Cylinder Montfort, 1810synonym of Conus (Cylinder) Montfort, 1810 represented as Conus Linnaeus, 1758 Dalliconus Tucker & Tenorio, 2009: synonym of Conasprella (Dalliconus) Tucker & Tenorio, 2009 synonym of Conasprella Thiele, 1929 Darioconus Iredale, 1930: synonym of Conus (Darioconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Dauciconus Cotton, 1945: synonym of Conus (Dauciconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Dendroconus Swainson, 1840: synonym of Conus (Dendroconus) Swainson, 1840 represented as Conus Linnaeus, 1758 Ductoconus da Motta, 1991: synonym of Conus (Ductoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Duodenticonus Tucker & Tenorio, 2013: synonym of Conasprella (Conasprella) Thiele, 1929 represented as Conasprella Thiele, 1929 Dyraspis Iredale, 1949: synonym of Conus (Virroconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Elisaconus Tucker & Tenorio, 2013: synonym of Conus (Elisaconus) Tucker & Tenorio, 2013 represented as Conus Linnaeus, 1758 Embrikena Iredale, 1937: synonym of Conus (Embrikena) Iredale, 1937 represented as Conus Linnaeus, 1758 Endemoconus Iredale, 1931: synonym of Conasprella (Endemoconus) Iredale, 1931 represented as Conasprella Thiele, 1929 Eremiconus Tucker & Tenorio, 2009: synonym of Conus (Eremiconus) Tucker & Tenorio, 2009 represented as Conus Linnaeus, 1758 Erythroconus da Motta, 1991: synonym of Conus (Darioconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Eugeniconus da Motta, 1991: synonym of Conus (Eugeniconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Floraconus Iredale, 1930: synonym of Conus (Floraconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Fraterconus Tucker & Tenorio, 2013: synonym of Conus (Fraterconus) Tucker & Tenorio, 2013 represented as Conus Linnaeus, 1758 Fulgiconus da Motta, 1991: synonym of Conus (Phasmoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Fumiconus da Motta, 1991: synonym of Conasprella (Fusiconus) da Motta, 1991 represented as Conasprella Thiele, 1929 Fusiconus da Motta, 1991: synonym of Conasprella (Fusiconus) da Motta, 1991 represented as Conasprella Thiele, 1929 Gastridium Modeer, 1793: synonym of Conus (Gastridium) Modeer, 1793 represented as Conus Linnaeus, 1758 Genuanoconus Tucker & Tenorio, 2009: synonym of Conus (Kalloconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Gladioconus Tucker & Tenorio, 2009: synonym of Conus (Monteiroconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Globiconus Tucker & Tenorio, 2009: synonym of Conasprella (Ximeniconus) Emerson & Old, 1962 represented as Conasprella Thiele, 1929 Gradiconus da Motta, 1991: synonym of Conus (Dauciconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Graphiconus da Motta, 1991: synonym of Conus (Phasmoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Harmoniconus da Motta, 1991: synonym of Conus (Harmoniconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Hermes Montfort, 1810: synonym of Conus (Hermes) Montfort, 1810 represented as Conus Linnaeus, 1758 Heroconus da Motta, 1991: synonym of Conus (Pionoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Isoconus Tucker & Tenorio, 2013: synonym of Conus (Splinoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Jaspidiconus Petuch, 2004: synonym of Conasprella (Ximeniconus) Emerson & Old, 1962 represented as Conasprella Thiele, 1929 Kalloconus da Motta, 1991: synonym of Conus (Kalloconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Kellyconus Petuch, 2013: synonym of Conus (Kellyconus) Petuch, 2013 represented as Conus Linnaeus, 1758 Kenyonia Brazier, 1896: genus incertae sedis Kermasprella Powell, 1958: synonym of Conasprella (Endemoconus) Iredale, 1931 represented as Conasprella Thiele, 1929 Ketyconus da Motta, 1991: synonym of Conus (Floraconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Kioconus da Motta, 1991: synonym of Conus (Splinoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Klemaeconus Tucker & Tenorio, 2013: synonym of Conus (Klemaeconus) Tucker & Tenorio, 2013 represented as Conus Linnaeus, 1758 Kohniconus Tucker & Tenorio, 2009: synonym of Conasprella (Kohniconus) Tucker & Tenorio, 2009 represented as Conasprella Thiele, 1929 Kurodaconus Shikama & Habe, 1968: synonym of Conus (Turriconus) Shikama & Habe, 1968 represented as Conus Linnaeus, 1758 Lamniconus da Motta, 1991: synonym of Conus (Lamniconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Lautoconus Monterosato, 1923: synonym of Conus (Lautoconus) Monterosato, 1923 represented as Conus Linnaeus, 1758 Leporiconus Iredale, 1930: synonym of Conus (Leporiconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Leptoconus Swainson, 1840: synonym of Conus (Leptoconus) Swainson, 1840 represented as Conus Linnaeus, 1758 Lilliconus Raybaudi Massilia, 1994: synonym of Conasprella (Lilliconus) G. Raybaudi Massilia, 1994 represented as Conasprella Thiele, 1929 Lindaconus Petuch, 2002: synonym of Conus (Lindaconus) Petuch, 2002 represented as Conus Linnaeus, 1758 Lithoconus Mörch, 1852: synonym of Conus (Lithoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Lividoconus Wils, 1970: synonym of Conus (Lividoconus) Wils, 1970 represented as Conus Linnaeus, 1758 Lizaconus da Motta, 1991synonym of Profundiconus Kuroda, 1956 Magelliconus da Motta, 1991: synonym of Conus (Dauciconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Malagasyconus Monnier & Tenorio, 2015 Mamiconus Cotton & Godfrey, 1932: synonym of Endemoconus Iredale, 1931synonym of Conasprella (Endemoconus) Iredale, 1931 represented as Conasprella Thiele, 1929 Miliariconus Tucker & Tenorio, 2009: synonym of Conus (Virroconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Mitraconus Tucker & Tenorio, 2013: synonym of Conus (Turriconus) Shikama & Habe, 1968 represented as Conus Linnaeus, 1758 Monteiroconus da Motta, 1991: synonym of Conus (Monteiroconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Nataliconus Tucker & Tenorio, 2009: synonym of Conus (Leptoconus) Swainson, 1840 represented as Conus Linnaeus, 1758 Nimboconus Tucker & Tenorio, 2013: synonym of Conus (Phasmoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Nitidoconus Tucker & Tenorio, 2013: synonym of Conus (Splinoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Ongoconus da Motta, 1991: synonym of Conus (Splinoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Papyriconus Tucker & Tenorio, 2013: synonym of Conus (Papyriconus) Tucker & Tenorio, 2013 represented as Conus Linnaeus, 1758 Parviconus Cotton & Godfrey, 1932: synonym of Conasprella (Parviconus) Cotton & Godfrey, 1932 represented as Conasprella Thiele, 1929 Perplexiconus Tucker & Tenorio, 2009: synonym of Conasprella (Ximeniconus) Emerson & Old, 1962 represented as Conasprella Thiele, 1929 Phasmoconus Mörch, 1852: synonym of Conus (Phasmoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Pionoconus Mörch, 1852: synonym of Conus (Pionoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Plicaustraconus Moolenbeek, 2008: synonym of Conus (Plicaustraconus) Moolenbeek, 2008 represented as Conus Linnaeus, 1758 Poremskiconus Petuch, 2013: synonym of Conus (Dauciconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Profundiconus Kuroda, 1956: accepted name Protoconus da Motta, 1991: synonym of Tenorioconus Petuch & Drolshagen, 2011 Protostrioconus Tucker & Tenorio, 2009: synonym of Conus (Gastridium) Modeer, 1793 represented as Conus Linnaeus, 1758 Pseudoconorbis Tucker & Tenorio, 2009: synonym of Conasprella (Pseudoconorbis) Tucker & Tenorio, 2009, represented as Conasprella Thiele, 1929 Pseudohermes Tucker & Tenorio, 2013: synonym of Conus (Virgiconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Pseudolilliconus Tucker & Tenorio, 2009: synonym of Conus (Pseudolilliconus) Tucker & Tenorio, 2009 represented as Conus Linnaeus, 1758 Pseudonoduloconus Tucker & Tenorio, 2009: synonym of Conus (Pseudonoduloconus) Tucker & Tenorio, 2009 represented as Conus Linnaeus, 1758 Pseudopterygia Tucker & Tenorio, 2013: synonym of Conus (Pseudopterygia) Tucker & Tenorio, 2013 represented as Conus Linnaeus, 1758 Puncticulis Swainson, 1840: synonym of Conus (Puncticulis) Swainson, 1840 represented as Conus Linnaeus, 1758 Purpuriconus da Motta, 1991: synonym of Conus (Dauciconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Pygmaeconus Puillandre & Tenorio, 2017 Pyruconus Olsson, 1967: synonym of Conus (Pyruconus) Olsson, 1967 represented as Conus Linnaeus, 1758 Quasiconus Tucker & Tenorio, 2009: synonym of Conus (Quasiconus) Tucker & Tenorio, 2009 represented as Conus Linnaeus, 1758 Regiconus Iredale, 1930: synonym of Conus (Darioconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Rhizoconus Mörch, 1852: synonym of Conus (Rhizoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Rhombiconus Tucker & Tenorio, 2009: synonym of Conus (Stephanoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Rhombus Montfort, 1810: synonym of Rhombiconus Tucker & Tenorio, 2009, synonym of Conus (Stephanoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Rolaniconus Tucker & Tenorio, 2009: synonym of Conus (Strategoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Rollus Montfort, 1810 :synonym of Conus (Gastridium) Modeer, 1793 represented as Conus Linnaeus, 1758 Rubroconus Tucker & Tenorio, 2013: synonym of Conus (Rubroconus) Tucker & Tenorio, 2013 represented as Conus Linnaeus, 1758 Sandericonus Petuch, 2013: synonym of Conus (Sandericonus) Petuch, 2013 represented as Conus Linnaeus, 1758 Sciteconus da Motta, 1991: synonym of Conus (Sciteconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Seminoleconus Petuch, 2003: synonym of Conus (Stephanoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Socioconus da Motta, 1991: synonym of Conus (Pionoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Splinoconus da Motta, 1991: synonym of Conus (Splinoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Spuriconus Petuch, 2003: synonym of Conus (Lindaconus) Petuch, 2002 represented as Conus Linnaeus, 1758 Stellaconus Tucker & Tenorio, 2009: synonym of Conus (Splinoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Stephanoconus Mörch, 1852: synonym of Conus (Stephanoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Strategoconus da Motta, 1991: synonym of Conus (Strategoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Strioconus Thiele, 1929: synonym of Pionoconus Mörch, 1852, synonym of Conus (Pionoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Sulciconus Bielz, 1869: synonym of Asprella Schaufuss, 1869, synonym of Conus (Asprella) Schaufuss, 1869 represented as Conus Linnaeus, 1758 Taranteconus Azuma, 1972: synonym of Conus (Stephanoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Tenorioconus Petuch & Drolshagen, 2011: synonym of Conus (Stephanoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Tesselliconus da Motta, 1991: synonym of Conus (Tesselliconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Textilia Swainson, 1840: synonym of Conus (Textilia) Swainson, 1840 represented Conus Linnaeus, 1758 Thalassiconus Tucker & Tenorio, 2013: synonym of Calibanus da Motta, 1991, synonym of Conus (Calibanus) da Motta, 1991 represented as Conus Linnaeus, 1758 Theliconus Swainson, 1840: synonym of Hermes Montfort, 1810, synonym of Conus (Hermes) Montfort, 1810 represented as Conus Linnaeus, 1758 Thoraconus da Motta, 1991: synonym of Fulgiconus da Motta, 1991, synonym of Conus (Phasmoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Trovaoconus Tucker & Tenorio, 2009, synonym of Conus (Kalloconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Tuckericonus Petuch, 2013: synonym of Conus (Dauciconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Tuliparia Swainson, 1840: synonym of Gastridium Modeer, 1793, synonym of Conus (Gastridium) Modeer, 1793 represented as Conus Linnaeus, 1758 Turriconus Shikama & Habe, 1968, synonym of Conus (Turriconus) Shikama & Habe, 1968 represented as Conus Linnaeus, 1758 Utriculus Schumacher, 1817: synonym of Gastridium Modeer, 1793, synonym of Conus (Gastridium) Modeer, 1793 represented as Conus Linnaeus, 1758 Varioconus da Motta, 1991: synonym of Conus (Lautoconus) Monterosato, 1923 represented as Conus Linnaeus, 1758 Viminiconus Tucker & Tenorio, 2009: synonym of Conasprella (Fusiconus) da Motta, 1991 represented as Conasprella Thiele, 1929 Virgiconus Cotton, 1945: synonym of Conus (Virgiconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Virroconus Iredale, 1930: synonym of Conus (Virroconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Vituliconus da Motta, 1991: synonym of Conus (Strategoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Ximeniconus Emerson & Old, 1962: synonym of Conasprella (Ximeniconus) Emerson & Old, 1962 represented as Conasprella Thiele, 1929 Yeddoconus Tucker & Tenorio, 2009: synonym of Conasprella (Endemoconus) Iredale, 1931 represented as Conasprella Thiele, 1929
=== Psoriatic arthritis === In psoriatic arthritis (PsA), inhibitors of TNF, such as infliximab, improve the signs and symptoms. Several therapies with modest efficacy have been studied in nail psoriasis. Among available agents, higher quality data are available to support the efficacy of cyclosporine and infliximab. Based on studies in AS, the results suggest infliximab, etanercept, and adalimumab have the potential to reduce the signs and symptoms of moderate to severely active axial involvement in PsA in patients who have had an inadequate response to NSAID (level 1a, grade A). The anti-TNF agents (infliximab and etanercept; level 1b, grade A) are more effective for the treatment of enthesitis than traditional agents. Results suggest infliximab is effective for the treatment of dactylitis in PsA.
==== Staudinger ligation with azides ==== The Staudinger ligation of azides and phosphine has been used extensively in field of chemical biology. Because it is able to form a stable amide bond in living cells and animals, it has been applied to modification of cell membrane, in vivo imaging, and other bioconjugation studies.
Sources: en.wikipedia.org
IGFRs and estrogen coaction facilitates growth in different breast cancer cell lines, however amplification of IGF1R signalling can abrogate need of estrogen for transformation and growth of MCF-7 cells. IRS-1 overexpression in breast cancer cells decreased estrogen requirements. This decrease is dependent on IRS-1 levels in the cells. Estradiol enhances expression of IRS-1 and activity of ERK1/2 and PI3K/Akt pathways in MCF-7 and CHO cells transfected with mouse IRS-1 promoter. Estradiol acts directly on IRS-1 regulatory sequences and positively regulates IRS-1 mRNA production. Decreased anchorage- dependent/independent cell growth and initiation of cell death under low growth factor and estrogen conditions are observed in MCF-7 cells with down-regulated IRS-1. mir126 is underexpressed in breast cancer cells. mir126 targets IRS-1 at transcriptional level and inhibits transition from G1/G0 phase to S phase during cell cycle in HEK293 and MCF-7 cells. Transgenic mice overexpressing IRS-1 develop metastatic breast cancer. The tumors demonstrate squamous differentiation which is associated with β-catenin pathway. IRS-1 interacts with β-catenin both in vitro and in vivo. IRS-1 and its homologue IRS-2 play distinct roles in breast cancer progression and metastasis. Overexpression of either one is sufficient to cause tumorogenesis in vivo. Frequency of lung metastasis in IRS-1 deficient tumor is elevated opposing to IRS-2 deficient tumor, where it is decreased.
=== Biosynthesis === DHEA is produced in the zona reticularis of the adrenal cortex under the control of adrenocorticotropic hormone (ACTH) and by the gonads under the control of gonadotropin-releasing hormone (GnRH). It is also produced in the brain. DHEA is synthesized from cholesterol via the enzymes cholesterol side-chain cleavage enzyme (CYP11A1; P450scc) and 17α-hydroxylase/17,20-lyase (CYP17A1), with pregnenolone and 17α-hydroxypregnenolone as intermediates. It is derived mostly from the adrenal cortex, with only about 10% being secreted from the gonads. Approximately 50 to 70% of circulating DHEA originates from desulfation of DHEA-S in peripheral tissues. DHEA-S itself originates almost exclusively from the adrenal cortex, with 95 to 100% being secreted from the adrenal cortex in women.
Differential cross section measurements were commonly made, for example, to study the structure of the atomic nucleus by scattering from them nucleons, such as neutrons. It is important to distinguish between differential light scattering and dynamic light scattering, both of which are referred to by the initials DLS. The latter refers to a technique that is quite different, measuring the fluctuation of scattered light due to constructive and destructive interference, the frequency being linked to the thermal motion, Brownian motion of the molecules or particles in solution or suspension. A MALS measurement requires a set of ancillary elements. Most important among them is a collimated or focused light beam (usually from a laser source producing a collimated beam of monochromatic light) that illuminates a region of the sample. In modern instruments, the beam is generally plane-polarized perpendicular to the plane of measurement, though other polarizations may be used especially when studying anisotropic particles. Earlier measurements, before the introduction of lasers, were performed using focused, though unpolarized, light beams from sources such as Hg-arc lamps. Another required element is an optical cell to hold the sample being measured. Alternatively, cells incorporating means to permit measurement of flowing samples may be employed. If single-particles scattering properties are to be measured, a means to introduce such particles one-at-a-time through the light beam at a point generally equidistant from the surrounding detectors must be provided.
== Enrichment steps == The peptide-mRNA:cDNA fusions can be selected over immobilized selection targets for several rounds (Figure 3). There might be a relatively high background for the first few rounds of selection, and this can be minimized by increasing selection stringency, such as adjusting salt concentration, amount of detergent, and/or temperature during the target/fusion binding period. Following binding selection, those library members that stay bound to the immobilized target are PCR amplified. The PCR amplification step will enrich the population from the mRNA-display library that has higher affinity for the immobilized target. Error-prone PCR can also be done in between each round of selection to further increase the diversity of the mRNA-display library and reduce background in selection. A less time-consuming protocol for mRNA display was recently published.
Sources: en.wikipedia.org
It binds and activates PPARδ, a nuclear receptor that influences gene expression related to fatty acid metabolism and energy balance. This mechanism has been studied mainly in animals and cell models, not established as a safe human therapy.
No. It is not an anabolic-androgenic steroid; it is a synthetic PPARδ agonist. Because it is banned in sport, it is sometimes grouped with doping agents even though its chemical class differs from steroids.
Human data are limited and development was discontinued, so major effects and long-term risks are not well characterized. Some early studies examined metabolic markers, but they do not provide a basis for unsupervised use.
No. Major drug regulators have not approved GW501516 for treating any medical condition. Products sold as cardarine are typically unapproved research chemicals or supplements, so their contents and safety are not assured.